For more than 40 years, Dr. Gordon Crofoot has advanced HIV care through groundbreaking research, compassionate medicine, and ...

More than 40 years have passed since the CDC reported the first cases of HIV in the United States. In that time, we’ve ...

With prompt diagnosis and the right treatment, people with HIV can live long, healthy lives. In recent years, however, gains in survival among people with HIV have exposed a new concern – an increase ...

Addressing the question of whether and how immune cells (macrophages) in the central nervous system (CNS) traffic out, ...

Zdenek Hel, Ph.D., a professor in the UAB Department of Pathology’s Division of Molecular and Cellular Pathology, received a five-year, $3.6 million R01 to support his project, “Dysregulated ...

BOSTON – Boston Medical Center has been using a new HIV molecular test as part of a series of tests used to diagnose and confirm HIV infection from a patient’s blood. Published in the American Journal ...

Background. Many human immunodeficiency virus (HIV)-2-infected individuals remain aviremic and behave as long-term non-progressors but some progress to AIDS. We hypothesized that immune activation and ...

The National Institutes of Health has awarded approximately $30 million in annual funding over the next five years to six research collaborations working to advance basic medical science toward an HIV ...

It is clear that ongoing immune activation and inflammation are associated with poor disease prognosis in HIV infection. Specifically, elevated plasma levels of IL-6 are a strong predictor of morbid ...

This project will provide an overall picture of lung cancer in East Africa specifically in Uganda and Tanzania and clarify the role of HIV-1 infection as a risk factor for lung cancer and progression.